Soonchunhyang Med Sci.
2024 Jun;30(1):32-35. 10.15746/sms.24.005.
Low-Dose Baclofen-Induced Encephalopathy in a Patient with End-Stage Renal Disease: A Case Report
- Affiliations
-
- 1Department of Neurology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
- KMID: 2556925
- DOI: http://doi.org/10.15746/sms.24.005
Abstract
- Baclofen, a gamma-aminobutyric acid-B receptor agonist, is commonly used for central-origin muscle spasticity and spasm and neuropathic pain. Baclofen toxicity has been reported to cause a range of symptoms including drowsiness, confusion, respiratory depression, seizures, and even coma, particularly with dosage significantly exceeding therapeutic levels. Given that the baclofen is predominantly eliminated through the kidneys, patients with renal failure are at substantial risk for neurotoxic effects. We report a case of baclofen-induced encephalopathy in a patient with end-stage renal disease, characterized by an altered mental state with myoclonus following the consumption of a low dose of baclofen.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Baclofen-induced Encephalopathy
- A Case Report of Acute Transient Encephalopathy Induced by Low Dose Baclofen
- A Case of Baclofen-Induced Encephalopathy in a Patient with ESRD on Continuous Ambulatory Peritoneal Dialysis
- A Case of Baclofen-Associated Encephalopathy in a Maintenance Hemodialysis Patient
- A Case Report of Acute Encephalopathy by Aluminum Intoxication with Subdural Hematoma in End Stage Renal Failure
